Correction To: KIF5B-RET Fusion Kinase Promotes Cell Growth by Multilevel Activation of STAT3 in Lung Cancer

Yingying Qian,Shoujie Chai,Zuyu Liang,Yongfang Wang,You Zhou,Xia Xu,Chenchen Zhang,Min Zhang,Jingxing Si,Feiteng Huang,Zhangdan Huang,Wei Hong,Kai Wang

DOI: https://doi.org/10.1186/s12943-019-1093-0

IF: 37.3

2019-01-01

Molecular Cancer

Abstract:After the publication of this work [1],

What problem does this paper attempt to address?

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Xia Li,Xiufeng Yin,Huafeng Wang,Jiansong Huang,Mengxia Yu,Zhixin Ma,Chenying Li,Yile Zhou,Xiao Yan,ShuJuan Huang,Jie Jin

DOI: https://doi.org/10.18632/oncotarget.27310

2019-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14463.].
Correction: Caveolin-1-mediated STAT3 Activation Determines Electrotaxis of Human Lung Cancer Cells

Li,Kejun Zhang,Conghua Lu,Qin Sun,Sanjun Zhao,Lin Jiao,Rui Han,Caiyu Lin,Jianxin Jiang,Min Zhao,Yong He

DOI: https://doi.org/10.18632/oncotarget.25675

2018-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.21306.].
Identification of a novel KIF13A-RET fusion in lung adenocarcinoma by next-generation sequencing

Xuefei Zhang,Yanlin Li,Changhong Liu,Weifeng Wang,Mo Li,Desheng Lv,Ge Sun,Hui Chen,Xiaowei Dong,Zhibo Miao,Ming Yao,Kai Wang,Hui Tian

DOI: https://doi.org/10.1016/j.lungcan.2017.08.019

IF: 6.081

2018-01-01

Lung Cancer

Abstract:Objectives RET fusions have been reported in 1–2% of lung adenocarcinomas, and represent an actionable target. Patients whose tumors possess RET fusion are associated with clinical benefit from the treatment with multi-kinase inhibitors such as cabozantinib and vandetanib. Further molecular screening for RET fusions is warranted. Novel KIF13A-RET fusion containing an intact RET kinase domain involving exons 1–18 of KIF13A and exons 12–20 of RET was identified in a lung cancer specimen from an 74-year-old Asian never smoker by next-generation sequencing (NGS) during clinical care. The patient was negative for EGFR, ALK, ROS1 and other putative driver alterations. Fusion analysis is consistent with other described RET fusions and is predicted to result in aberrant constitutive activation caused by dimerization and sensitivity to RET-directed therapies. We describe a novel RET-fusion with molecular characteristics consistent with RET-driven non-small cell lung cancer. Our case expands the spectrum of RET fusion partners and supports broad molecular profiling in non-small cell lung cancer optimizing patient therapeutic options. The new RET fusion has immediate clinical implications for cancer patients.
Correction To: MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Jing Zheng,Tao Xu,Feng Chen,Ying Zhang

DOI: https://doi.org/10.1007/s12253-020-00794-3

2020-01-01

Abstract:The original version of this article unfortunately contained an error in the affiliation section.
Correction to: PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3

Qian-Wen Zheng,Qian-Zhi Ni,Bing Zhu,Xin Liang,Ning Ma,Yi-Kang Wang,Sheng Xu,Hui-Jun Cao,Ji Xia,Feng-Kun Zhang,Er-Bin Zhang,Xiao-Song Qiu,Xu-Fen Ding,Lin Qiu,Xi-Lin Zhang,Zhao-Hui Dong,Zhi-Gang Li,Xue-Li Zhang,Dong Xie,Jing-Jing Li

DOI: https://doi.org/10.1038/s41388-023-02735-1

IF: 8.756

2023-07-26

Oncogene

Abstract:Oncogene, Published online: 25 July 2023; doi:10.1038/s41388-023-02735-1 Correction to: PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3

oncology,genetics & heredity,biochemistry & molecular biology,cell biology
Correction: Corrigendum: Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model

Yifeng Xia,Narayana Yeddula,Mathias Leblanc,Eugene Ke,Yonghui Zhang,Eric Oldfield,Reuben J. Shaw,Inder M. Verma

DOI: https://doi.org/10.1038/ncb3145

IF: 21.3

2015-01-01

Nature Cell Biology

Abstract:Nat. Cell Biol. 14, 257–265 (2012); published online 12 February 2012; corrected after print 26 February 2015 The version of this Article originally published should have acknowledged that this work was also supported by NIH grant number CA158191. This has been corrected in all online versions of the Article.
Correction to: NUPR1 promotes the proliferation and metastasis of oral squamous cell carcinoma cells by activating TFE3-dependent autophagy

Tengfei Fan,Xiaoning Wang,Sheng Zhang,Ping Deng,Yi Jiang,Yidan Liang,Sheng Jie,Qing Wang,Chuwen Li,Guocai Tian,Zhen Zhang,Zhenhu Ren,Bo Li,Yanrong Chen,Zhijing He,Yan Luo,Mingliang Chen,Hanjiang Wu,Zhengping Yu,Huifeng Pi,Zhou Zhou,Zhiyuan Zhang

DOI: https://doi.org/10.1038/s41392-022-01154-0

IF: 39.3

2022-09-18

Signal Transduction and Targeted Therapy

Abstract:Signal Transduction and Targeted Therapy, Published online: 16 September 2022; doi:10.1038/s41392-022-01154-0 Correction to: NUPR1 promotes the proliferation and metastasis of oral squamous cell carcinoma cells by activating TFE3-dependent autophagy

biochemistry & molecular biology,cell biology
Correction to: FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway

Cheng-Cao Sun,Wei Zhu,Shu-Jun Li,Wei Hu,Jian Zhang,Yue Zhuo,Han Zhang,Juan Wang,Yu Zhang,Shao-Xin Huang,Qi-Qiang He,De-Jia Li

DOI: https://doi.org/10.1186/s13073-021-00834-w

IF: 15.266

2021-02-11

Genome Medicine

Abstract:An amendment to this paper has been published and can be accessed via the original article.

genetics & heredity
Correction: TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas

Jiabo Li,Xuya Wang,Lulu Chen,Jinhao Zhang,Yiming Zhang,Xiao Ren,Jinzhang Sun,Xiaoguang Fan,Jikang Fan,Tao Li,Luqing Tong,Li Yi,Lei Chen,Jie Liu,Guanjie Shang,Xiude Ren,Hao Zhang,Shengping Yu,Haolang Ming,Qiang Huang,Jun Dong,Chen Zhang,Xuejun Yang

DOI: https://doi.org/10.1038/s41417-024-00733-3

IF: 5.854

2024-01-26

Cancer Gene Therapy

Abstract:Cancer Gene Therapy, Published online: 26 January 2024; doi:10.1038/s41417-024-00733-3 Correction: TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas

oncology,genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology
Correction To: Minichromosome Maintenance 3 Promotes Hepatocellular Carcinoma Radioresistance by Activating the NF-κB Pathway.

Qing Yang,Binhui Xie,Hui Tang,Wei Meng,Changchang Jia,Xiaomei Zhang,Yi Zhang,Jianwen Zhang,Heping Li,Binsheng Fu

DOI: https://doi.org/10.1186/s13046-019-1338-1

2019-01-01

Abstract:In the original publication of this article [1], the authors reported the order of the authors was incorrect and needs to be revised. The original article has been updated to rectify this error.
Author Correction: Targeted Inhibition of STAT/TET1 Axis As a Therapeutic Strategy for Acute Myeloid Leukemia

Xi Jiang,Chao Hu,Kyle Ferchen,Ji Nie,Xiaolong Cui,Chih-Hong Chen,Liting Cheng,Zhixiang Zuo,William Seibel,Chunjiang He,Yixuan Tang,Jennifer R. Skibbe,Mark Wunderlich,William C. Reinhold,Lei Dong,Chao Shen,Stephen Arnovitz,Bryan Ulrich,Jiuwei Lu,Hengyou Weng,Rui Su,Huilin Huang,Yungui Wang,Chenying Li,Xi Qin,James C. Mulloy,Yi Zheng,Jiajie Diao,Jie Jin,Chong Li,Paul P. Liu,Chuan He,Yuan Chen,Jianjun Chen

DOI: https://doi.org/10.1038/s41467-018-02947-0

IF: 16.6

2018-01-01

Nature Communications

Abstract:The original version of this Article contained an error in the spelling of the author James C. Mulloy, which was incorrectly given as James Mulloy. This has now been corrected in both the PDF and HTML versions of the Article.
Correction: Regua et al. TrkA Interacts with and Phosphorylates STAT3 to Enhance Gene Transcription and Promote Breast Cancer Stem Cells in Triple-Negative and HER2-Enriched Breast Cancers. Cancers 2021, 13, 2340

Angelina T. Regua,Noah R. Aguayo,Sara Abu Jalboush,Daniel L. Doheny,Sara G. Manore,Dongqin Zhu,Grace L. Wong,Austin Arrigo,Calvin J. Wagner,Yang Yu,Alexandra Thomas,Michael D. Chan,Jimmy Ruiz,Guangxu Jin,Roy Strowd,Peiqing Sun,Jiayuh Lin,Hui-Wen Lo

DOI: https://doi.org/10.3390/cancers16193409

2024-10-09

Cancers

Abstract:Cancers, Vol. 16, Pages 3409: Correction: Regua et al. TrkA Interacts with and Phosphorylates STAT3 to Enhance Gene Transcription and Promote Breast Cancer Stem Cells in Triple-Negative and HER2-Enriched Breast Cancers. Cancers 2021, 13, 2340 Cancers doi: 10.3390/cancers16193409 Authors: Angelina T. Regua Noah R. Aguayo Sara Abu Jalboush Daniel L. Doheny Sara G. Manore Dongqin Zhu Grace L. Wong Austin Arrigo Calvin J. Wagner Yang Yu Alexandra Thomas Michael D. Chan Jimmy Ruiz Guangxu Jin Roy Strowd Peiqing Sun Jiayuh Lin Hui-Wen Lo In the original publication [...]

oncology
Correction: ZHX2 Drives Cell Growth and Migration Via Activating MEK/ERK Signal and Induces Sunitinib Resistance by Regulating the Autophagy in Clear Cell Renal Cell Carcinoma

Zhu, Liangsong,Ding, Rong,Yan, Hao,Zhang, Jin,Lin, Zongming

DOI: https://doi.org/10.1038/s41419-021-03678-9

2021-01-01

Abstract:A Correction to this paper has been published: https://doi.org/10.1038/s41419-021-03678-9
Correction: Clinical Significance and Effect of AEG-1 on the Proliferation, Invasion, and Migration of NSCLC: a Study Based on Immunohistochemistry, TCGA, Bioinformatics, in Vitro and in Vivo Verification.

Yu Zhang,Zu-Yun Li,Xin-Xi Hou,Xiao Wang,Yi-Huan Luo,Yan-Ping Ying,Gang Chen

DOI: https://doi.org/10.18632/oncotarget.28212

2022-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14972.].
Correction: Yao, Y., et al. Activation of Slit2/Robo1 Signaling Promotes Tumor Metastasis in Colorectal Carcinoma through Activation of the TGF-β/Smads Pathway. Cells 2019, 8, 635

Yuying Yao,Zijun Zhou,Liuyou Li,Junchen Li,Lixun Huang,Jiangchao Li,Cuiling Qi,Lingyun Zheng,Lijing Wang,Qian-Qian Zhang

DOI: https://doi.org/10.3390/cells9081918

IF: 6

2020-08-18

Cells

Abstract:The author wishes to make the following correction to this paper [...]

cell biology
Correction: GATA3 suppresses human fibroblasts-induced metastasis of clear cell renal cell carcinoma via an anti-IL6/STAT3 mechanism

Qianqian Shi,Renfang Xu,Guanglai Song,Hao Lu,Dong Xue,Xiaozhou He,Ying Xia

DOI: https://doi.org/10.1038/s41417-020-00229-w

IF: 5.854

2020-11-06

Cancer Gene Therapy

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

oncology,genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology
Correction: Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC

Zi Wang,Bianying Ma,Hui Li,Xiaojuan Xiao,Weihua Zhou,Feng Liu,Bin Zhang,M. Zhu,Qin Yang,Yayue Zeng,Yang Sun,Shuming Sun,Yanpeng Wang,Yibin Zhang,Haibo Weng,Lixiang Chen,Mao Ye,X. An,Jing Liu

DOI: https://doi.org/10.18632/oncotarget.27282

2019-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.6312.].
Correction to: LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway

Kun Qiao,Shipeng Ning,Lin Wan,Hao Wu,Qin Wang,Xingda Zhang,Shouping Xu,Da Pang

DOI: https://doi.org/10.1186/s13046-020-01645-4

2020-08-11

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology
Erratum: STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling

G Wang,Y Yu,C Sun,T Liu,T Liang,L Zhan,X Lin,X-H Feng

DOI: https://doi.org/10.1038/onc.2016.145

IF: 8.756

2016-01-01

Oncogene

Abstract:Correction to: Oncogene (2015) 00, 1–11; doi:10.1038/onc.2015.446; published online 30 November 2015 Following the online publication of this article, it was noted that the final word ‘signalling’ had been erroneously missed off the title. The title has now been rectified. The authors apologise for any inconvenience caused by this error.
Correction: PLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3

Zhipeng Gao,Xiaojun Man,Zhenhua Li,Jianbin Bi,Xiankui Liu,Zeliang Li,Jun Li,Zhe Zhang,Chuize Kong

DOI: https://doi.org/10.1038/s41417-022-00458-1

IF: 5.854

2022-03-31

Cancer Gene Therapy

Abstract:Cancer Gene Therapy, Published online: 31 March 2022; doi:10.1038/s41417-022-00458-1Correction: PLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3

oncology,genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology

Correction To: KIF5B-RET Fusion Kinase Promotes Cell Growth by Multilevel Activation of STAT3 in Lung Cancer

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Correction: Caveolin-1-mediated STAT3 Activation Determines Electrotaxis of Human Lung Cancer Cells

Identification of a novel KIF13A-RET fusion in lung adenocarcinoma by next-generation sequencing

Correction To: MiRNA-195-5p Functions As a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1

Correction to: PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3

Correction: Corrigendum: Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model

Correction to: NUPR1 promotes the proliferation and metastasis of oral squamous cell carcinoma cells by activating TFE3-dependent autophagy

Correction to: FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway

Correction: TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas

Correction To: Minichromosome Maintenance 3 Promotes Hepatocellular Carcinoma Radioresistance by Activating the NF-κB Pathway.

Author Correction: Targeted Inhibition of STAT/TET1 Axis As a Therapeutic Strategy for Acute Myeloid Leukemia

Correction: Regua et al. TrkA Interacts with and Phosphorylates STAT3 to Enhance Gene Transcription and Promote Breast Cancer Stem Cells in Triple-Negative and HER2-Enriched Breast Cancers. Cancers 2021, 13, 2340

Correction: ZHX2 Drives Cell Growth and Migration Via Activating MEK/ERK Signal and Induces Sunitinib Resistance by Regulating the Autophagy in Clear Cell Renal Cell Carcinoma

Correction: Clinical Significance and Effect of AEG-1 on the Proliferation, Invasion, and Migration of NSCLC: a Study Based on Immunohistochemistry, TCGA, Bioinformatics, in Vitro and in Vivo Verification.

Correction: Yao, Y., et al. Activation of Slit2/Robo1 Signaling Promotes Tumor Metastasis in Colorectal Carcinoma through Activation of the TGF-β/Smads Pathway. Cells 2019, 8, 635

Correction: GATA3 suppresses human fibroblasts-induced metastasis of clear cell renal cell carcinoma via an anti-IL6/STAT3 mechanism

Correction: Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC

Correction to: LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway

Erratum: STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling

Correction: PLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3